The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation
Abstract
Share and Cite
Stephens, E.; Greenhough, A.; Mansell, J.P. The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation. Int. J. Mol. Sci. 2025, 26, 9675. https://doi.org/10.3390/ijms26199675
Stephens E, Greenhough A, Mansell JP. The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation. International Journal of Molecular Sciences. 2025; 26(19):9675. https://doi.org/10.3390/ijms26199675
Chicago/Turabian StyleStephens, Emily, Alexander Greenhough, and Jason P. Mansell. 2025. "The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation" International Journal of Molecular Sciences 26, no. 19: 9675. https://doi.org/10.3390/ijms26199675
APA StyleStephens, E., Greenhough, A., & Mansell, J. P. (2025). The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation. International Journal of Molecular Sciences, 26(19), 9675. https://doi.org/10.3390/ijms26199675